Our Products
Anti Allergic Drug
1 Products availableCatalysts And Absorbents
1 Products availablePharmaceutical Chemical
1 Products availableAntibiotic Drugs
1 Products availableLeading Manufacturer, Supplier & Retailer of Sildenafil Oral Jelly, CADRONAX Tablets, MIDORYX Injection, Omeprazole Capsules and XLORITOM Injection.
Additional Information:
Payment Terms : L/C, D/A, T/T
Packaging Details : Remdesivir Injection 100 Mg/Vial
Remdetaj 100mg Injection is a broad-spectrum antiviral medicine. It is used for the treatment of suspected or laboratory-confirmed coronavirus disease 2019 (COVID-19) in adults and children hospitalized with severe disease. The medicine decreases the viral load in the body and speeds up the recovery process.
How Remdetaj 100mg Injection is used?
Remdetaj 100mg Injection works by inhibiting an RNA-dependent enzyme called RNA polymerase that helps the SARS-CoV-2 virus make more copies of itself. This medicine is given as an injection into veins under the supervision of a doctor. You should take this medicine only for the prescription of your doctor. Take it only as per the dose and duration suggested by your doctor. You should not self-medicate this medicine.
Common Side effects of This Medicine:
Some common side effects of this medicine include anemia, fever, acute kidney injury, increased blood glucose, and increased transaminases. These are usually mild and short-lived. It may also cause shortness of breath or low blood pressure in some people. To reduce the risk of side effects, your doctor will probably start the medicine at a low dose and gradually increase it. Consult your doctor if the side effects bother you or do not go away.
Precautions:
Before taking it, let your doctor know if you have any liver problems. It may also not be suitable for people who have a slow heart rate, severe circulation problems, severe heart failure, or low blood pressure. Pregnant or breastfeeding mothers should also consult their doctor before taking it. You must talk to your doctor to find out whether this medicine is suitable for you to use. You should have your blood pressure checked regularly to make sure that this medicine is working properly. Avoid drinking alcohol as it may increase certain side effects. For other details Read More.
Brand Name: Remdetaj
Manufacturer: Taj Pharma
Presentation: Injection
Strength: 100mg
Delivery Time : 1 Week
300 MG TABS BUPROPRION ( PACKOF 30 TABS)INR 476.00 + 10 Tablets
Pheniramine maleate
Antihistamine
[132-20-7]
Under development
Tranexamic Acid
Antifibrinolytic Agent
[1197-18-8]
Under development
Rasagiline mesylate
Monoamine oxidase inhibitor (MAOI)
[161735-79-1]
Leveteracitam
Anticonvulsant
[102767-28-2]
Tech pack available
Hexylresorcinol
Antiseptic & Anthelmintic
[136-77-6]
Tech pack available
Selegiline hydrochloride
Antiparkinson
[14611-52-0]
Tech pack available
Amoxicillin(amoxycillin) is an antibiotic useful for the treatment of a number of bacterial infections. It is the first line treatment for middle ear infections. It may also be used for strep throat, pneumonia, skin infections, and urinary tract infections among others.
Diosmin is a type of plant chemical found mainly in citrus fruits. People use diosmin to make medicine.Diosmin is used for treating various disorders of blood vessels including hemorrhoids, varicose veins, poor circulation in the legs (venous stasis), and bleeding (hemorrhage) in the eye or gums.
CAS ID: 520-27-4
Molar mass: 608.545 g/mol
Formula: C28H32O15
ATC code: C05CA03 (WHO)
DrugBank: DB08995
PubChem CID: 5281613
Class: a type of plant chemical found mainly in citrus fruits.
Indications:
Internal hemorrhoids, when used in combination with diosmin. The combination of hesperidin
and diosmin seems to both significantly improve symptoms of hemorrhoids and also keep
hemorrhoids, once healed, from coming back.
Treating leg ulcers caused by poor circulation, when used in combination with diosmin.
Hesperidin, in combination with diosmin and a compression dressing, seems to improve
healing of small ulcers (less than 10 cm) caused by poor blood circulation.
Available dosage form in the hospital:
DIOSMEN 450MG + HESPIRIDIN 50MG TABLET
Trade Names:
Dosage:
BY MOUTH:
For the treatment of internal hemorrhoids: 1350 mg of diosmin plus 150 mg of
hesperidin twice daily for 4 days followed by 900 mg of diosmin and 100 mg of
hesperidin twice daily for 3 days. Some researchers also try 600 mg of diosmin three
times daily for 4 days, followed by 300 mg twice daily for 10 days, in combination
with 11 grams of psyllium daily. However, this lower diosmin dose does not seem to
be as effective.
For prevention of relapse internal hemorrhoids: 450 mg of diosmin plus 50 mg of
hesperidin twice daily for 3 months of therapy.
For the treatment of leg wounds due to bloodflow problems (venous stasis ulcers): the
combination of 900 mg of diosmin and 100 mg of hesperidin daily has been used for
up to 2 months.
Common side effect: Diosmin is safe for most people when used short-term for up to three
months. It can cause some side effects such as stomach and abdominal pain, diarrhea, and
headache.
Do not take diosmin for more than three months without medical supervision.
Pregnancy Risk Factor:
Not enough is known about the use of diosmin during pregnancy and breast-feeding. Stay on
the safe side and avoid use.
Packaging Size- 40 Capsule
Composition-Molnupiravir
Treatment-Covid 19
Strength-200 Mg
Prescription/Non prescription-Prescription
Brand-Molnutaj
Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication.
The drug was developed at Emory University by the university's drug innovation company, Drug Innovation Ventures at Emory (DRIVE). It was then acquired by Miami-based company Ridgeback Biotherapeutics, who later partnered with Merck & Co. to develop the drug further.
Safety controversyIn April 2020, a whistleblower complaint by former Head of US Biomedical Advanced Research and Development Authority (BARDA) Rick Bright revealed concerns over providing funding for the further development of molnupiravir due to similar drugs having mutagenic (DNA damaging) properties.[3] A previous company, Pharmasset, that had investigated the drug's active ingredient had abandoned it. These claims were denied by George Painter, CEO of DRIVE, noting that toxicity studies on molnupiravir had been carried out and data provided to regulators in the US and UK, who permitted safety studies in humans to move forward in the spring of 2020. Also at this time, DRIVE and Ridgeback Biotherapeutics stated they planned future safety studies in animals.
COVID-19In late July 2020 Merck, which had been partnering with Ridgeback Biotherapeutics on developing the drug, announced its intention to move molnupiravir to late stage trials beginning in September 2020. On October 19 2020, Merck began a one year Stage 2/3 trial focused on hospitalized patients.
Additional Information:
Payment Terms :
Packaging Details : #Molnupiravir has received both international and national approvals to manage the high-risk progression of #Covid_19.
Don't let covid-19 cripple the pillars of Healthcare.
Identify early and move to #Molnutaj to reduce viral load and minimize the risk.
#TajPharmaceuticals
Molnupiravir 200 / 400 / 800 mg Capsule
40 Capsules/- Bottle
Molnupiravir is a medication that works by introducing errors into the SARS-CoV-2 virus' genetic code, which prevents the virus from further.
Hyderabad, Maharashtra 